Related Experiment Video
Updated: May 9, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Prospects of miRNA-based therapy for pancreatic cancer
Priya Pai1, Satyanarayana Rachagani, Chandrakanth Are
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USA.
Abstract:
Pancreatic cancer (PC) is the fourth leading cause of cancer related deaths in the U.S., with a less than 6% five-year survival rate. Treatment is confounded by advanced stage of disease at presentation, frequent metastasis to distant organs at the time of diagnosis and resistance to conventional chemotherapy. In addition, the molecular pathogenesis of the disease is unclear. The extensive study of miRNAs over the past several years has revealed that miRNAs are frequently de-regulated in pancreatic cancer and contribute to the pathogenesis and aggressiveness of the disease. Several studies have tackled the practical difficulties in the application of miRNAs as viable therapeutic and diagnostic tools. Given that a single miRNA can affect a myriad of cellular processes, successful targeting of miRNAs as therapeutic agents could likely yield dramatic results. The current review attempts to summarize the advances in the field and assesses the prospects for miRNA profiling and targeting in aiding PC treatment.
Insights
MicroRNAs (miRNAs) are key players in pancreatic cancer (PC) development and progression. This review explores how targeting these molecules offers new therapeutic and diagnostic strategies for this deadly disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer (PC) has a low survival rate and is often diagnosed at advanced stages.
- Metastasis and chemotherapy resistance complicate PC treatment.
- The molecular basis of PC remains incompletely understood.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in pancreatic cancer.
- To assess the potential of miRNA profiling for diagnosis.
- To evaluate miRNA targeting as a therapeutic strategy for PC.
Main Methods:
- Literature review of studies on miRNAs in pancreatic cancer.
- Analysis of miRNA dysregulation in PC pathogenesis.
- Evaluation of current and future applications of miRNAs in PC treatment.
Main Results:
- miRNAs are frequently dysregulated in PC and contribute to its aggressiveness.
- Targeting miRNAs could offer significant therapeutic benefits.
- miRNA profiling shows promise for diagnostic applications.
Conclusions:
- miRNAs are crucial in pancreatic cancer development and progression.
- Targeting miRNAs presents a promising avenue for novel PC therapies.
- Further research into miRNA profiling and targeting is warranted for improved PC management.
Related Concept Videos
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

